Verona Pharma plc ( VRNA) - Key Metrics
Stock symbol VRNA is outdated, potentially delisted? Maybe it is available on other exchange?
VRNA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q1 | $0.90 | -$0.19 | -$0.14 | -$0.14 |
| 2024Q4 | $0.45 | -$0.41 | -$0.35 | -$0.36 |
| 2024Q3 | $0.07 | -$0.53 | -$0.77 | -$0.77 |
| 2024Q2 | ? | -$0.88 | -$0.21 | -$0.21 |
| 2024Q1 | ? | -$0.32 | -$0.17 | -$0.17 |
VRNA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q1 | ? | -82.60 |
| 2024Q4 | ? | -27.99 |
| 2024Q3 | ? | -13.64 |
| 2024Q2 | ? | -4.43 |
| 2024Q1 | ? | -12.56 |
VRNA
Price: $106.91
52 week price:
Earnings Per Share: -1.04 USD
P/E Ratio: -102.70
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 555000
Ebitda: -10.7 millionMarket Capitalization: 9.1 billion